Tower Bridge Advisors Merck & Co., Inc. Transaction History

Tower Bridge Advisors

$939 Billion
Q4 2024

A detailed history of Tower Bridge Advisors transactions in Merck & Co., Inc. stock. As of the latest transaction made, Tower Bridge Advisors holds 48,066 shares of MRK stock, worth $4.56 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares

48,066

Previous 48,500 0.89%

Holding current value

$4.56 Million

Previous $5.51 Billion 13.18%

% of portfolio

0.51%

Previous 0.57%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 05, 2025	SELL	$96.31 - $114.76 $41,798 - $49,805	-434 Reduced 0.89%	48,066 $4.78 Billion
Q3 2024 Nov 06, 2024	BUY	$111.15 - $128.97 $156,165 - $181,202	1,405 Added 2.98%	48,500 $5.51 Billion
Q2 2024 Jul 24, 2024	SELL	$123.8 - $132.96 $131,475 - $141,203	-1,062 Reduced 2.21%	47,095 $5.83 Billion
Q1 2024 Apr 29, 2024	SELL	$113.24 - $131.95 $56,506 - $65,843	-499 Reduced 1.03%	48,157 $6.35 Billion
Q4 2023 Feb 14, 2024	SELL	$100.18 - $109.02 $69,825 - $75,986	-697 Reduced 1.41%	48,656 $5.3 Billion
Q3 2023 Nov 01, 2023	SELL	$102.95 - $114.33 $128,378 - $142,569	-1,247 Reduced 2.46%	49,353 $5.08 Billion
Q2 2023 Jul 20, 2023	SELL	$108.61 - $118.38 $1.56 Million - $1.7 Million	-14,356 Reduced 22.1%	50,600 $5.84 Billion
Q1 2023 Apr 26, 2023	BUY	$102.94 - $114.86 $154,410 - $172,290	1,500 Added 2.36%	64,956 $6.91 Billion
Q4 2022 Jan 27, 2023	SELL	$87.44 - $112.11 $18,974 - $24,327	-217 Reduced 0.34%	63,456 $7.04 Billion
Q3 2022 Nov 14, 2022	SELL	$84.53 - $94.96 $53,253 - $59,824	-630 Reduced 0.98%	63,673 $5.48 Billion
Q2 2022 Jul 21, 2022	BUY	$83.49 - $94.64 $43,247 - $49,023	518 Added 0.81%	64,303 $5.86 Billion
Q1 2022 May 05, 2022	BUY	$73.51 - $82.4 $32,638 - $36,585	444 Added 0.7%	63,785 $5.23 Billion
Q4 2021 Feb 09, 2022	SELL	$72.28 - $90.54 $92,446 - $115,800	-1,279 Reduced 1.98%	63,341 $4.85 Billion
Q3 2021 Oct 28, 2021	SELL	$71.68 - $78.83 $9,676 - $10,642	-135 Reduced 0.21%	64,620 $4.85 Billion
Q2 2021 Aug 10, 2021	SELL	$70.31 - $77.77 $19,686 - $21,775	-280 Reduced 0.43%	64,755 $5.04 Billion
Q1 2021 May 12, 2021	SELL	$68.86 - $81.11 $89,035 - $104,875	-1,293 Reduced 1.95%	65,035 $5.01 Billion
Q4 2020 Feb 11, 2021	BUY	$71.77 - $79.65 $1.87 Million - $2.07 Million	26,050 Added 64.68%	66,328 $5.43 Billion
Q3 2020 Nov 13, 2020	BUY	$73.18 - $82.95 $19,758 - $22,396	270 Added 0.67%	40,278 $3.34 Billion
Q2 2020 Jul 22, 2020	SELL	$70.42 - $80.13 $204,218 - $232,377	-2,900 Reduced 6.76%	40,008 $3.09 Billion
Q1 2020 Apr 27, 2020	BUY	$63.36 - $87.82 $183,363 - $254,151	2,894 Added 7.23%	42,908 $3.3 Billion
Q4 2019 Feb 05, 2020	SELL	$77.58 - $87.54 $183,088 - $206,594	-2,360 Reduced 5.57%	40,014 $3.64 Billion
Q3 2019 Nov 12, 2019	SELL	$76.08 - $82.93 $132,683 - $144,629	-1,744 Reduced 3.95%	42,374 $3.54 Billion
Q2 2019 Aug 06, 2019	SELL	$69.84 - $81.59 $29,332 - $34,267	-420 Reduced 0.94%	44,118 $3.7 Billion
Q1 2019 Apr 30, 2019	SELL	$69.58 - $79.36 $16,351 - $18,649	-235 Reduced 0.52%	44,538 $3.7 Billion
Q4 2018 Feb 07, 2019	SELL	$65.24 - $75.71 $271,202 - $314,726	-4,157 Reduced 8.5%	44,773 $3.42 Billion
Q3 2018 Oct 23, 2018	SELL	$57.69 - $67.84 $197,184 - $231,877	-3,418 Reduced 6.53%	48,930 $3.47 Billion
Q2 2018 Aug 09, 2018	SELL	$50.83 - $59.72 $749,081 - $880,093	-14,737 Reduced 21.97%	52,348 $3.18 Billion
Q1 2018 May 02, 2018	SELL	$50.96 - $59.23 $1.93 Million - $2.25 Million	-37,964 Reduced 36.14%	67,085 $3.65 Billion
Q4 2017 Jan 30, 2018	SELL	$51.62 - $61.64 $856,995 - $1.02 Million	-16,602 Reduced 13.65%	105,049 $5.91 Billion
Q3 2017 Nov 06, 2017	BUY	$58.67 - $63.13 $7.14 Million - $7.68 Million	121,651	121,651 $7.79 Billion

Others Institutions Holding MRK

# of Institutions

3,970

Shares Held

1.94B

Call Options Held

16M

Put Options Held

15M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $240B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Bridge Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Tower Bridge Advisors with notifications on news.

Account

Tower Bridge Advisors Merck & Co., Inc. Transaction History